Sawhney Roger
Insider CIK 1858748 · ALIM Director · ABUS Director · ACTU Director · OMGA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABUS Arbutus Biopharma Corp | D To issuer | 2026-10-01 | 2026-10-07 | 17,142 | $5.00 | $85.7K | 13,683 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 78,800 | — | $0 | 0 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 52,533 | — | $0 | 105,067 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 52,533 | $3.34 | $175.5K | 52,533 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 78,800 | $4.24 | $334.1K | 131,333 | SEC↗ |
| ABUS Arbutus Biopharma Corp | F Tax w/h | 2026-09-18 | 2026-09-23 | 100,508 | $5.07 | $509.6K | 30,825 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 78,800 | — | $0 | 0 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 52,533 | — | $0 | 105,067 | SEC↗ |
| ABUS Arbutus Biopharma Corp | F Tax w/h | 2026-09-18 | 2026-09-23 | 100,508 | $5.07 | $509.6K | 30,825 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 78,800 | $4.24 | $334.1K | 131,333 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 52,533 | $3.34 | $175.5K | 52,533 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2026-06-08 | 2026-06-10 | 78,800 | — | $0 | 78,800 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | A Award deriv | 2026-05-21 | 2026-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2025-08-04 | 2025-08-06 | 157,600 | — | $0 | 157,600 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | A Award deriv | 2025-05-22 | 2025-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACTU ACTUATE THERAPEUTICS, INC. | A Award deriv | 2024-08-12 | 2024-08-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2023-02-25 | 2023-03-01 | 2,252 | — | $0 | 2,252 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2022-03-09 | 2022-03-11 | 60,000 | — | $0 | 60,000 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-03 | 2,941 | $17.00 | $50.0K | 2,941 | SEC↗ |